Ketamine is one of the most widely-used anesthetics, and is considered the most
“cardiopulmonary stable“ of all anesthetic agents.
Ketamine is on WHO’s list of “Essential Medications,” and is classified as a “Dissociative.”
In 2019, ketamine was approved by the FDA for use in Treatment-Resistant Depression, and its OFF LABEL uses include: Chronic Pain, Migraines, PTSD, Anxiety Disorder, Bipolar Depression, Substance Abuse disorders, Fibromyalgia, CRPS, Rheumatoid Arthritis, Inclusion-Body Myositis, Phantom Limb Pain, Chronic Lyme Disease, etc.
Ketamine treatment results in HUGE increases in BDNF levels (Brain Derived Neurotrophic Factor), increases synapse repair & function, and promotes dendritic spine formation.
Ketamine has Anti-inflammatory & immune-modulating actions.
There is no long-term adverse effects, and is NON-ADDICTIVE in controlled outpatient settings.
Ketamine offers RAPID results (including instantaneous reversal of suicidal ideation) – often after on a single dose, with 80% response rate, and >50% improvement in
When a person is under Ketamine treatment, there is heightened gamma wave activity in the brain, which is most-often associated with what’s known as the “zone,” the “flow,” a heightened & sustained focus, or expanded consciousness.
Ketamine’s benefit is a result of its multitude of mechanisms that alter brain activities, in contrast to the very limited mechanisms of actions from mainstream medications.